BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7594335)

  • 1. Comparison of lansoprazole and famotidine for gastric ulcer by endoscopic ultrasonography: a preliminary trial.
    Okai T; Sawabu N; Songür Y; Motoo Y; Watanabe H
    J Clin Gastroenterol; 1995; 20 Suppl 2():S32-5. PubMed ID: 7594335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine.
    Tsuji S; Kawano S; Higashi T; Mukuda T; Imaizumi T; Tatsumi T; Miura N; Miyajima K; Fukuda M; Noguchi M
    J Clin Gastroenterol; 1995; 20 Suppl 2():S1-4. PubMed ID: 7594320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
    Ogawa N
    Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic ultrasonographic evaluation of gastric ulcer healing on treatment with proton pump inhibitors versus H2-receptor antagonists.
    Tanaka M; Maruoka A; Chijiiwa Y; Tanaka M; Nawata H
    Scand J Gastroenterol; 1994 Dec; 29(12):1140-4. PubMed ID: 7886404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endosonographic evaluation of the quality of ulcer healing induced by proton pump inhibitors.
    Tsukamoto Y; Goto H; Hase S; Niwa Y; Arisawa T; Hayakawa T; Yoshikane H
    J Clin Gastroenterol; 1995; 20 Suppl 2():S40-3. PubMed ID: 7594337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical effectiveness of lansoprazole in patients with gastric ulcers: evaluation of quality of ulcer healing based on endoscopic ultrasonographic findings.
    Obara K; Kuwana T; Ishihata R; Kondo Y; Ejiri Y; Yokogi K; Okubo Y; Ajima H; Mukai S; Kasukawa R
    J Clin Gastroenterol; 1995; 20 Suppl 2():S36-9. PubMed ID: 7594336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
    Poynard T; Lemaire M; Agostini H
    Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of gastric ulcer healing by lansoprazole by measurement of ulcer diameter.
    Aoyama N; Kinoshita Y; Misaki F; Himeno S; Kasuga M; Chiba T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S86-9. PubMed ID: 7594351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of lansoprazole on mucosal regeneration in patients with gastric ulcers: evaluation using an electronic endoscope with a magnifying function.
    Hashimoto M; Hoshihara Y; Yamamoto T; Tanaka T; Kimura T; Iguchi D; Sugawara K; Fukuchi S; Takemoto T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S59-61. PubMed ID: 7594343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
    Spencer CM; Faulds D
    Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of lansoprazole on peptic ulcers in elderly patients.
    Murakami M; Saita H; Takahashi Y; Kusaka S; Asagoe K; Dekigai H; Matsumoto M; Seki M; Mizuno M; Maeda S
    J Clin Gastroenterol; 1995; 20 Suppl 2():S79-82. PubMed ID: 7594348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lansoprazole on peptic ulcers.
    Ohashi T; Sakata J; Haraguchi Y; Eto T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S83-5. PubMed ID: 7594350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lansoprazole compared with histamine2-receptor antagonists in healing gastric ulcers: a meta-analysis.
    Tunis SR; Sheinhait IA; Schmid CH; Bishop DJ; Ross SD
    Clin Ther; 1997; 19(4):743-57. PubMed ID: 9377618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
    Sasakii M; Joh T; Yokoyama Y; Seno K; Tsuchida K; Kurokawa T; Itoh M
    J Pharm Pharmacol; 1999 Jul; 51(7):825-30. PubMed ID: 10467958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
    Hotz J; Kleinert R; Grymbowski T; Hennig U; Schwarz JA
    Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
    Tomita T; Kim Y; Yamasaki T; Okugawa T; Kondo T; Toyoshima F; Sakurai J; Tanaka J; Morita T; Oshima T; Fukui H; Hori K; Watari J; Matsumoto T; Miwa H
    J Gastroenterol Hepatol; 2012 Sep; 27(9):1441-6. PubMed ID: 22497427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ranitidine on quality of gastric ulcer healing compared with famotidine: a randomized, controlled, multicenter trial.
    Higuchi K; Watanabe T; Tominaga K; Shiba M; Nakagawa K; Uno H; Kitada K; Satoh H; Chono S; Uchida T; Fujiwara Y; Arakawa T
    Int J Clin Pharmacol Res; 2005; 25(4):187-94. PubMed ID: 16402635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive therapy for non-steroidal anti-inflammatory drug-induced ulcers in Japanese patients with rheumatoid arthritis: the current situation and a prospective controlled-study of the preventive effects of lansoprazole or famotidine.
    Miyake K; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Hiratsuka T; Nishigaki H; Tatsuguchi A; Futagami S; Wada K; Tsukui T; Nakajima A; Yoshino S; Sakamoto C
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():67-72. PubMed ID: 15943850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.